Cervical Cancer Detection Kit

The kit can in vitro qualitative detection the 28 types of human papillomaviruses (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53 , 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acid, but can not be completely typed. It can only provide auxiliary means for the diagnosis and treatment of HPV infection.

Epidemiology

Cervical cancer is one of the most common malignant tumors in the female reproductive tract. The studies have shown that persistent infection and multiple infections of human papillomavirus is one of the important cause of cervical cancer. At present, there is still a lack of recognized effective treatment methods for HPV. Therefore, early detection and early prevention of cervical HPV is the key to blocking canceration. The establishment of a simple, specific and rapid pathogenic diagnostic method is of great significance in the clinical diagnosis of cervical cancer.

Technical Parameters

Storage - ≤-18℃ in dark
Shelf-life - 12 months
Specimen Type - Cervical exfoliated cells
Ct - ≤28
CV - ≤5.0％
LoD - 25 Copies/reaction

Specificity -
No cross-reactivity with common reproductive tract pathogens (such as ureaplasma urealyticum, genital tract chlamydia trachomatis, candida albicans, neisseria gonorrhoeae, trichomonas vaginalis, mold, gardnerella and other HPV types not covered in the kit, etc).

Applicable Instruments
-
It can match the mainstream fluorescent PCR instruments on the market.
ABI 7500 Real-Time PCR Systems
QuantStudio® 5 Real-Time PCR Systems
SLAN-96P Real-Time PCR Systems
LightCycler®480 Real-Time PCR system
LineGene 9600 Plus Real-Time PCR Detection System
MA-6000 Real-Time Quantitative Thermal Cycler